These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Washington MC, Raboin SJ, Thompson W, Larsen CJ, Sayegh AI. Brain Res; 2010 Jul 16; 1344():124-33. PubMed ID: 20452329 [Abstract] [Full Text] [Related]
3. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR. Endocrinology; 2005 Dec 16; 146(12):5120-7. PubMed ID: 16150917 [Abstract] [Full Text] [Related]
8. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat. Raboin SJ, Reeve JR, Cooper MS, Green GM, Sayegh AI. Regul Pept; 2008 Oct 09; 150(1-3):73-80. PubMed ID: 18620003 [Abstract] [Full Text] [Related]
9. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Chelikani PK, Haver AC, Reidelberger RD. Endocrinology; 2005 Feb 09; 146(2):879-88. PubMed ID: 15539554 [Abstract] [Full Text] [Related]
10. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats. Mhalhal TR, Washington MC, Newman K, Heath JC, Sayegh AI. Physiol Behav; 2017 Oct 01; 179():191-199. PubMed ID: 28647503 [Abstract] [Full Text] [Related]
11. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Riediger T, Bothe C, Becskei C, Lutz TA. Neuroendocrinology; 2004 Oct 01; 79(6):317-26. PubMed ID: 15256809 [Abstract] [Full Text] [Related]
13. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR. Brain Res; 2005 May 10; 1043(1-2):139-44. PubMed ID: 15862527 [Abstract] [Full Text] [Related]
16. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats. Chelikani PK, Haver AC, Reidelberger RD. Diabetes; 2006 Nov 10; 55(11):3038-46. PubMed ID: 17065340 [Abstract] [Full Text] [Related]
18. Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval. Washington MC, Coggeshall J, Sayegh AI. Peptides; 2011 May 10; 32(5):971-7. PubMed ID: 21335043 [Abstract] [Full Text] [Related]
19. Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats. Washington MC, Mhalhal TR, Sayegh AI. Horm Behav; 2016 Sep 10; 85():36-42. PubMed ID: 27497934 [Abstract] [Full Text] [Related]